Effects of a blend of essential oils, medium-chain fatty acids, and a toxin-adsorbing mineral on diarrhea and gut microbiome of weanling pigs experimentally infected with a pathogenic Escherichia coli.
Escherichia coli challenge
antimicrobial feed additive
diarrhea
microbiome
weaned pigs
Journal
Journal of animal science
ISSN: 1525-3163
Titre abrégé: J Anim Sci
Pays: United States
ID NLM: 8003002
Informations de publication
Date de publication:
01 Jan 2022
01 Jan 2022
Historique:
received:
22
10
2021
accepted:
15
12
2021
pubmed:
18
12
2021
medline:
2
2
2022
entrez:
17
12
2021
Statut:
ppublish
Résumé
A proprietary antimicrobial feed additive comprised of essential oils, medium-chain fatty acids, and a toxin-adsorbing mineral showed promising bacteriostatic and bactericidal effects in vitro. This study investigated the impacts of supplementing this blend on growth, gut microbiome, and enteric disease resilience in weaned pigs experimentally challenged with an enterotoxigenic Escherichia coli (ETEC). Thirty-six weanling pigs (6.88 ± 0.30 kg body weight) blocked by weight and gender were assigned to one of three dietary treatments: control or dietary supplementation with 0.25% or 0.50% of the antimicrobial blend. This study lasted 28 d with 7 d before and 21 d after the first ETEC inoculation (day 0). All pigs were orally inoculated with 1010 CFU F18 + ETEC/3-mL dose for 3 consecutive days. Growth performance data and diarrhea scores were recorded throughout the experiment. Fecal samples collected on days -7, 0, 7, and 21 post first inoculation (PI), and ileal digesta and mucosal tissue collected on day 21 PI were further analyzed for gut microbiome using 16S rRNA sequencing. All data, except for frequency of diarrhea and gut microbiome, were analyzed by ANOVA using the PROC MIXED of SAS. The chi-square test was used for analyzing frequency of diarrhea. Gut microbiome data were analyzed using QIIME2 and visualized using the R program. Dietary supplementation of 0.25% or 0.5% of the antimicrobial blend increased (P < 0.05) feed efficiency on days 14 to 21 PI of ETEC and reduced (P < 0.05) frequency of diarrhea during the study. Compared with the control group, adding 0.5% dietary antimicrobial blend increased (P < 0.05) relative abundance of Firmicutes but reduced (P < 0.05) Bacteroidetes and Proteobacteria in feces on day 7 PI. Pigs that received the antimicrobial blend also had higher (P < 0.05) relative abundance of Lactobacillaceae, but lower (P < 0.05) relative abundance of Enterobacteriaceae in feces on day 7 PI than pigs in control. In conclusion, supplementation of this antimicrobial blend at 0.5% reduced incidence of severe diarrhea in weaned pigs challenged with F18 ETEC and enhanced feed efficiency of weaned pigs at the last week of the experiment. Supplementation of this antimicrobial blend also modified the microbiota diversity in feces and ileal mucosa of weaned pigs. This experiment aims to investigate an antimicrobial blend consisting of essential oils, medium-chain fatty acids, and a toxin-adsorbing mineral on diarrhea, growth performance, and gut microbiome of newly weaned pigs experimentally infected with a pathogenic Escherichia coli (F18 E. coli). A total of 36 weaned pigs were randomly allotted to one of three dietary treatments: (1) a complex control diet that met the nutrient requirement of weaned pigs; (2) supplementing 0.25% of the antimicrobial blend; and (3) 0.50% of the antimicrobial blend. The experiment lasted 28 d with 7 d adaptation and 21 d after the first F18 E. coli inoculation. Results of this experiment demonstrate that supplementation of this antimicrobial blend enhanced disease resistance of weaned pigs, as indicated by reduced frequency of diarrhea during the entire experimental period. An improved feed efficiency was also observed in pigs supplemented with antimicrobial blend at the last week of the experiment. In addition, feces collected on day 7 post-E. coli inoculation contained relatively more Lactobacillaceae but less Enterobacteriaceae when pigs were supplemented with this antimicrobial blend. In conclusion, supplementation of antimicrobial blend could reduce diarrhea of E. coli-infected pigs and modify fecal microbiome of weaned pigs during the peak of E. coli infection.
Autres résumés
Type: plain-language-summary
(eng)
This experiment aims to investigate an antimicrobial blend consisting of essential oils, medium-chain fatty acids, and a toxin-adsorbing mineral on diarrhea, growth performance, and gut microbiome of newly weaned pigs experimentally infected with a pathogenic Escherichia coli (F18 E. coli). A total of 36 weaned pigs were randomly allotted to one of three dietary treatments: (1) a complex control diet that met the nutrient requirement of weaned pigs; (2) supplementing 0.25% of the antimicrobial blend; and (3) 0.50% of the antimicrobial blend. The experiment lasted 28 d with 7 d adaptation and 21 d after the first F18 E. coli inoculation. Results of this experiment demonstrate that supplementation of this antimicrobial blend enhanced disease resistance of weaned pigs, as indicated by reduced frequency of diarrhea during the entire experimental period. An improved feed efficiency was also observed in pigs supplemented with antimicrobial blend at the last week of the experiment. In addition, feces collected on day 7 post-E. coli inoculation contained relatively more Lactobacillaceae but less Enterobacteriaceae when pigs were supplemented with this antimicrobial blend. In conclusion, supplementation of antimicrobial blend could reduce diarrhea of E. coli-infected pigs and modify fecal microbiome of weaned pigs during the peak of E. coli infection.
Identifiants
pubmed: 34919701
pii: 6468858
doi: 10.1093/jas/skab365
pmc: PMC8827030
pii:
doi:
Substances chimiques
Fatty Acids
0
Minerals
0
Oils, Volatile
0
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society of Animal Science. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Sci Rep. 2019 Sep 24;9(1):13773
pubmed: 31551432
J Anim Sci Biotechnol. 2020 Sep 15;11:101
pubmed: 32944236
Animal. 2014 Nov;8(11):1777-87
pubmed: 25046106
Microbiome. 2020 Nov 18;8(1):161
pubmed: 33208178
J Anim Sci. 2012 Aug;90(8):2774-83
pubmed: 22328722
ISME J. 2011 Apr;5(4):627-38
pubmed: 20981114
Gut Pathog. 2013 Aug 13;5(1):23
pubmed: 23941657
Mucosal Immunol. 2017 Jan;10(1):18-26
pubmed: 27554295
J Nutr. 2001 May;131(5):1520-7
pubmed: 11340110
Front Microbiol. 2020 Nov 25;11:593056
pubmed: 33324372
J Anim Sci Biotechnol. 2018 Jul 30;9:54
pubmed: 30069307
Anim Nutr. 2018 Jun;4(2):113-125
pubmed: 30140751
Int J Med Microbiol. 2005 Oct;295(6-7):443-54
pubmed: 16238018
Acta Vet Scand. 2017 May 19;59(1):31
pubmed: 28526080
J Anim Sci. 2021 Mar 1;99(3):
pubmed: 33693730
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Magn Reson Med. 2002 Aug;48(2):255-61
pubmed: 12210933
ISME J. 2012 Aug;6(8):1621-4
pubmed: 22402401
Molecules. 2019 Oct 19;24(20):
pubmed: 31635062
Front Vet Sci. 2019 Feb 21;6:46
pubmed: 30847348
Appl Environ Microbiol. 2019 Sep 17;85(19):
pubmed: 31324635
Vet Microbiol. 2013 May 3;163(3-4):392-4
pubmed: 23395292
J Am Vet Med Assoc. 2007 Jul 1;231(1):56-67
pubmed: 17605665
Appl Microbiol Biotechnol. 2018 Mar;102(5):2289-2299
pubmed: 29362824
ISME J. 2012 Jul;6(7):1415-26
pubmed: 22258098
Sci Rep. 2018 May 17;8(1):7788
pubmed: 29773876
J Anim Sci. 2018 Sep 7;96(9):3777-3790
pubmed: 29982429
J Anim Sci. 2020 Apr 1;98(4):
pubmed: 32215565
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4586-91
pubmed: 10200306
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
J Anim Sci. 2012 Jan;90(1):345-60
pubmed: 21908641
Poult Sci. 2011 Oct;90(10):2217-22
pubmed: 21934003
J Anim Sci. 2020 Sep 1;98(9):
pubmed: 32877510
Microbiome. 2015 Jul 01;3:28
pubmed: 26167280
Infect Immun. 2001 Feb;69(2):1120-6
pubmed: 11160009
Anim Health Res Rev. 2005 Jun;6(1):17-39
pubmed: 16164007
Gut Microbes. 2011 Mar-Apr;2(2):99-104
pubmed: 21694499
Gastroenterology. 2014 Nov;147(5):1055-63.e8
pubmed: 25046162
FEMS Microbiol Ecol. 2003 Feb 1;43(1):1-11
pubmed: 19719691
J Anim Sci. 2013 Nov;91(11):5294-306
pubmed: 24045466
J Anim Sci Biotechnol. 2015 Aug 22;6(1):38
pubmed: 26301092
Symp Ser Soc Appl Microbiol. 2001;(30):16S-24S
pubmed: 11422557
J Appl Microbiol. 1999 Jun;86(6):985-90
pubmed: 10438227
J Anim Sci. 2016 Dec;94(12):5262-5271
pubmed: 28046155
Am J Clin Nutr. 2002 Nov;76(5):1117-25
pubmed: 12399288
Environ Microbiol. 2017 Apr;19(4):1425-1438
pubmed: 27871148
Gut Microbes. 2014;5(6):748-60
pubmed: 25536463
J Anim Sci. 2014 May;92(5):2050-62
pubmed: 24663182
Anim Health Res Rev. 2001 Dec;2(2):129-40
pubmed: 11831435
EcoSal Plus. 2016 Oct;7(1):
pubmed: 27735786
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Animal. 2013 Jul;7(7):1067-78
pubmed: 23410993
PLoS One. 2015 Feb 17;10(2):e0117441
pubmed: 25688558